Your session is about to expire
← Back to Search
Lidocaine Infusion for Pancreatic Cancer
Study Summary
This trial will investigate whether IV lidocaine affects the behavior of pancreatic CTCs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 1 & 2 trial • 26 Patients • NCT03254394Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What medical symptoms is Lidocaine Hydrochloride regularly administered to alleviate?
"Lidocaine Hydrochloride is commonly administered to reduce intra ocular pressure (IOP) and can also prove beneficial for treating nasal irritation, increased renal excretion of toxins, as well as sciatica."
How many participants are currently involved in this clinical trial?
"Affirmative. The clinical trial data available on clinicaltrials.gov confirms that the study, which originated on November 8th 2018, is currently recruiting patients. There needs to be 46 participants at one medical centre for this investigation to proceed."
Are participants being actively recruited for this experiment?
"The details available on clinicaltrials.gov suggest that this research is actively recruiting patients, with the initial posting taking place on November 8th 2018 and an update to the listing being made April 8th 2022."
Has there been prior experimentation utilizing Lidocaine Hydrochloride?
"At this moment, 211 clinical trials are being done to research the properties of Lidocaine Hydrochloride with 53 of those studies in their third phase. The vast majority of these tests take place near Duarte California, but 1461 different sites offer them worldwide."
Share this study with friends
Copy Link
Messenger